BR112018006431A2 - uma composição farmacêutica bactericida e virucida - Google Patents

uma composição farmacêutica bactericida e virucida

Info

Publication number
BR112018006431A2
BR112018006431A2 BR112018006431-9A BR112018006431A BR112018006431A2 BR 112018006431 A2 BR112018006431 A2 BR 112018006431A2 BR 112018006431 A BR112018006431 A BR 112018006431A BR 112018006431 A2 BR112018006431 A2 BR 112018006431A2
Authority
BR
Brazil
Prior art keywords
bactericidal
pharmaceutical composition
virucidal pharmaceutical
virucidal
nsaid
Prior art date
Application number
BR112018006431-9A
Other languages
English (en)
Inventor
Luis Alberto ARGAÑARÁS
Adrian Javier MUÑOZ
Roxana Valeria ALASINO
Ariel Gustavo GARRO
Dante Miguel Beltramo
Original Assignee
Quimica Luar S R L
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Quimica Luar S R L filed Critical Quimica Luar S R L
Publication of BR112018006431A2 publication Critical patent/BR112018006431A2/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/14—Alkali metal chlorides; Alkaline earth metal chlorides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Virology (AREA)
  • Engineering & Computer Science (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Inorganic Chemistry (AREA)
  • Pulmonology (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)

Abstract

composição farmacêutica bactericida e virucida uma composição farmacêutica bactericida e virucida para aplicação sobre epitélios de tecidos como pulmonar, nasal e bucal, compreendendo anti-inflamatório não esteroide (aine) em uma concentração entre 5 e 500 mm e um sal, o referido aine preferencialmente solubilizado em solução salina hipertônica, aplicável em terapias de infecções virais tipo herpes simples a ser empregada como enxágue bactericida bucal ou a ser levada ao pulmão por meio do uso de um nebulizador para fibrose quística.
BR112018006431-9A 2015-10-05 2016-10-04 uma composição farmacêutica bactericida e virucida BR112018006431A2 (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
ARP150103203A AR102172A1 (es) 2015-10-05 2015-10-05 Una composición farmacéutica bactericida y virucida
ARAR20150103203 2015-10-05
PCT/ES2016/070702 WO2017060550A1 (es) 2015-10-05 2016-10-04 Una composición farmacéutica bactericida y virucida

Publications (1)

Publication Number Publication Date
BR112018006431A2 true BR112018006431A2 (pt) 2018-12-11

Family

ID=58488060

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112018006431-9A BR112018006431A2 (pt) 2015-10-05 2016-10-04 uma composição farmacêutica bactericida e virucida

Country Status (8)

Country Link
US (2) US10973787B2 (pt)
EP (1) EP3360547B1 (pt)
AR (1) AR102172A1 (pt)
BR (1) BR112018006431A2 (pt)
ES (1) ES2928399T3 (pt)
PL (1) PL3360547T3 (pt)
PT (1) PT3360547T (pt)
WO (1) WO2017060550A1 (pt)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR102172A1 (es) * 2015-10-05 2017-02-08 Química Luar S R L Una composición farmacéutica bactericida y virucida
US20220040098A1 (en) * 2020-08-10 2022-02-10 Quimica Luar S.R.L. Methods for treating respiratory viral infections
CN112843092B (zh) * 2021-01-20 2022-05-10 朱有建 免疫细胞在治疗疾病中的应用及其制备方法
AR127532A1 (es) * 2021-12-01 2024-02-07 Quim Luar S R L Composición farmacéutica que comprende ibuprofeno y arginina

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS60184013A (ja) 1984-03-01 1985-09-19 Yoshitomi Pharmaceut Ind Ltd 点眼剤
TW358812B (en) * 1994-03-15 1999-05-21 Senju Pharma Co Method for stabilizing pranoprofen and a composition and a package thereof
US5885597A (en) 1997-10-01 1999-03-23 Medical Research Industries,Inc. Topical composition for the relief of pain
GB9823246D0 (en) * 1998-10-24 1998-12-16 Danbiosyst Uk A nasal drug delivery composition
US20030211173A1 (en) 2002-05-08 2003-11-13 Veach Tom C. Lubrication composition
US7452523B2 (en) * 2004-01-27 2008-11-18 Gilead Sciences, Inc. Targeted delivery of lidocaine and other local anesthetics and a method for treatment of cough and tussive attacks
WO2005102282A1 (en) * 2004-04-19 2005-11-03 Strategic Science & Technologies, Llc Transdermal delivery of beneficial substances effected by a hostile biophysical environment
US7186186B2 (en) * 2005-01-22 2007-03-06 Takeo Imahata Game apparatus having a ball drop mechanism
US20080260863A1 (en) * 2007-04-20 2008-10-23 Pre Holding, Inc. Compositions for mucociliary clearance and methods for administering same
US20100074881A1 (en) * 2008-07-11 2010-03-25 Parion Sciences, Inc. Multiple nebulizer systems
CN101550119B (zh) 2009-05-11 2012-05-30 无锡宏瑞生物医药科技有限公司 芳基(乙)丙酸抗坏血酸酯,其制备方法及含有它们的药物
AU2009348470B2 (en) * 2009-06-24 2015-04-02 Strategic Science & Technologies, Llc Topical composition containing ibuprofen
GB2477590A (en) 2010-02-05 2011-08-10 Biocopea Ltd A non-steroidal anti-inflammatory drug (NSAID) formulation comprising a lipid carrier
NZ588686A (en) 2011-01-20 2013-07-26 Bayer New Zealand Ltd Injectable composition comprising an NSAID and an antibiotic in a non-aqueous solvent for treating a microbial infection in a mammary gland
CN102138893A (zh) 2011-03-21 2011-08-03 陕西宏府怡悦制药有限公司 制备赖氨洛芬氯化钠注射液的工艺方法及其用途
ES2540151B1 (es) * 2013-10-11 2016-02-29 Farmalider S.A. Composición farmacéutica de ibuprofeno y tramadol para uso oftálmico
AR102172A1 (es) * 2015-10-05 2017-02-08 Química Luar S R L Una composición farmacéutica bactericida y virucida

Also Published As

Publication number Publication date
EP3360547A1 (en) 2018-08-15
EP3360547B1 (en) 2022-07-13
PT3360547T (pt) 2022-10-18
US11925612B2 (en) 2024-03-12
PL3360547T3 (pl) 2022-12-19
EP3360547A4 (en) 2019-08-21
WO2017060550A1 (es) 2017-04-13
US20180296509A1 (en) 2018-10-18
ES2928399T3 (es) 2022-11-17
US20210275476A1 (en) 2021-09-09
AR102172A1 (es) 2017-02-08
US10973787B2 (en) 2021-04-13

Similar Documents

Publication Publication Date Title
CL2020000122A1 (es) Métodos de tratamiento para la fibrosis quística.
BR112018006431A2 (pt) uma composição farmacêutica bactericida e virucida
AR088381A1 (es) Formulaciones de etanercept estabilizadas con meglumina
SV2018005778A (es) Derivados aromaticos de sulfonamida
BR112015007366A2 (pt) derivados de acilaminopirimidina para o tratamento de infecções virais e outras doenças
BR112015025854A2 (pt) flagelina de roseburia e modulação imunológica
CL2012001836A1 (es) Compuestos de pirazol, antagonista de crth2; composicion farmacéutica; uso en el tratamiento de trastornos inflamatorios, infecciosos, inmunoreguladores, enfermedades respiratorias, gastrointestinales o dolencias, entre otros.
PE20170183A1 (es) Composiciones estables de yodo no en complejo y metodos de uso
BR112014024672A8 (pt) Composições farmacêuticas para terapia de combinação
BR112015008987A2 (pt) composto ou um sal farmaceuticamente aceitável do mesmo, composição farmacêutica, e, uso de uma composição farmacêutica
CL2018000033A1 (es) Composición para destapar una nariz tapada que tiene actividad antiviral.
ECSP109889A (es) Composiciones terapeuticas y usos de las mismas
BR112013029269A8 (pt) combinação farmacêutica para uso na indução de perda de peso em pacientes com diabetes tipo 2 e/ou para prevenir o ganho de peso em pacientes com diabetes tipo 2
BR112012004692B8 (pt) solução que compreende levofloxacina para uso em um método para tratar a fibrose cística em um ser humano
BR112015014174A2 (pt) composição de vacina para indivíduos virgens
BR112019003136A2 (pt) forma de dosagem multiunitária de composição farmacêutica, forma de dosagem unitária de composição farmacêutica, forma de dosagem multiunitária / unitária, kit e método de tratamento de uma condição tratável por administração oral de um agente terapeuticamente ativo
CL2010001459A1 (es) Compuesto derivados de benzoxazinona; compuesto intermediarios; composicion y combinacion farmaceutica; y uso para el trratamiento de enfermedades tales como insuficiencia respiratoria en el adulto, enfisema pulmonar, bronquitis, epoc, entre otras.
BR112016015997A2 (pt) ?composições farmacêuticas que compreendem 15- hepe e métodos para tratar asma e distúrbios pulmonares com o uso das mesmas?
BR112017028137A2 (pt) agente terapêutico para fibrose
BR112014014973A2 (pt) preparações contendo emodepside amorfo
BR112019001134A2 (pt) uso de lactama e composição farmacêutica
BR112015028890A2 (pt) derivados de piridona para o tratamento de infecções virais e outras doenças
RU2014130894A (ru) Пептид, обладающий нейропротекторной и ноотропной активностью, и фармацевтическая композиция на его основе
BR112017006816A2 (pt) dispositivo de inalação.
PH12015502717A1 (en) Anti-fibrogenic compounds, methods and uses thereof

Legal Events

Date Code Title Description
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]

Free format text: DE ACORDO COM O ARTIGO 229-C DA LEI NO 10196/2001, QUE MODIFICOU A LEI NO 9279/96, A CONCESSAO DA PATENTE ESTA CONDICIONADA A ANUENCIA PREVIA DA ANVISA. CONSIDERANDO A APROVACAO DOS TERMOS DO PARECER NO 337/PGF/EA/2010, BEM COMO A PORTARIA INTERMINISTERIAL NO 1065 DE 24/05/2012, ENCAMINHA-SE O PRESENTE PEDIDO PARA AS PROVIDENCIAS CABIVEIS.

B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]
B06U Preliminary requirement: requests with searches performed by other patent offices: procedure suspended [chapter 6.21 patent gazette]
B350 Update of information on the portal [chapter 15.35 patent gazette]
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]
B12B Appeal against refusal [chapter 12.2 patent gazette]